Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese

Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01791439

Enrollment

Registered

2013-02-15

Start date

2013-01-31

Completion date

Unknown

Last updated

2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gagging

Brief summary

The investigators wish to determine if application of 2% lidocaine soaked gauze to the peritonsillar pillars will decrease the amount of gagging caused by awake videolaryngocope assisted tracheal intubation in the morbidly obese.

Interventions

OTHERlidocaine

Application of lidocaine to the glossopharyngeal nerve.

OTHERplacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* morbid obese patients scheduled for bariatric surgery, with a planned awake intubation.

Exclusion criteria

* inability to communicate in English or french * allergies to any study drugs * any patient with an American society of anesthesiologists score of 4 or more

Design outcomes

Primary

Measure	Time frame	Description
Gagging	2 minutes	We will assess the amount of gagging during the awake intubation.

Secondary

Measure	Time frame	Description
vital signs	2 minutes	we will asses vital signs during intubation.
lidocaine levels	40 minutes	—

Countries

Canada

Contacts

Primary ContactAlbert Moore, md

moore_albert@hotmail.com5149341934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026